e-learning
resources
Amsterdam 2015
Sunday, 27.09.2015
Emerging data on (e-)cigarettes and their health hazards
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Did the tobacco industry know that smoking caused cystic fibrosis-like lung disease before the scientific community?
Elif Dagli (Istanbul, Turkey), Elif Dagli
Source:
International Congress 2015 – Emerging data on (e-)cigarettes and their health hazards
Session:
Emerging data on (e-)cigarettes and their health hazards
Session type:
Oral Presentation
Number:
281
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Elif Dagli (Istanbul, Turkey), Elif Dagli. Did the tobacco industry know that smoking caused cystic fibrosis-like lung disease before the scientific community?. Eur Respir J 2015; 46: Suppl. 59, 281
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Panel discussion on Basic translational and clinical research – building a career in paediatric pulmonology- experiences from clinicians in lower middle income countries
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Physical activity for cystic fibrosis: perceptions of people with cystic fibrosis, parents and healthcare professionals
Source: ERJ Open Res, 6 (3) 00294-2019; 10.1183/23120541.00294-2019
Year: 2020
Impact of smoke-free workplace legislation on exposures and health: possibilities for prevention
Source: Eur Respir J 2006; 28: 397-408
Year: 2006
Smoking and the lung
Source: ISSN=1025-448x, ISBN=1-904097-22-7, page=60
Year: 2002
Assessment of public awareness on COPD in Singapore in a one-day awareness campaign
Source: International Congress 2016 – Public health related concerns and epidemiology of smoking and smoking-related products
Year: 2016
Health care system resource utilisation in patients with idiopathic pulmonary fibrosis
Source: International Congress 2016 – ILD: from the bench to the bedside
Year: 2016
Is electronic-cigarette a tobacco industry discovery?
Source: International Congress 2015 – E-cigarette, sisha and waterpipe
Year: 2015
Do physicians in primary health care recognize pulmonary fibrosis?
Source: International Congress 2015 – IPF: clinical aspects
Year: 2015
Pulmonary and systemic manifestations in asymptomatic smokers
Source: International Congress 2016 – The wide spectrum of respiratory nursing research and practice: across all ages and diseases
Year: 2016
Assessment of general physicians’ knowledge in the public and private sectors about interstitial lung disease.
Source: International Congress 2017 – IPF: from the bench to the bedside
Year: 2017
Workplace smoking restriction and respiratory health: the Irish experience
Source: Annual Congress 2005 - Environmental tobacco smoke and obstructive lung disease
Year: 2005
Smoking and lung function among adults with newly-onset asthma
Source: International Congress 2016 – Smoking-related diseases
Year: 2016
Public awareness on cystic fibrosis: results from a national pragmatic survey
Source: Eur Respir J 2015; 46: 264-267
Year: 2015
Clinical, functional and microbiological characteristics of an adult brazilian cystic fibrosis population
Source: International Congress 2014 – Cystic fibrosis: clinical assessment and treatment
Year: 2014
The prevalence and impact of cannabis smoking in clinical trial patients with chronic obstructive pulmonary disease
Source: International Congress 2015 – Kaleidoscope of nursing research
Year: 2015
Environmental tobacco smoke and health in the elderly
Source: Eur Respir J 2002; 19: 172-181
Year: 2002
Incidence and prevalence of IPF in an insurance claims database: Assessing accuracy using medical records
Source: International Congress 2014 – Respiratory disease within hospital-based populations
Year: 2014
Respiratory effects of cannabis smoking: A literature review
Source: International Congress 2016 – Prevalence, prognosis, and risk factors of COPD
Year: 2016
The effect of transition from a paediatric to adult cystic fibrosis (CF) centre on clinical status and hospital attendance
Source: International Congress 2016 – From pleura to bronchi: new insights
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept